Yaws 

  • Author: Natalie C Klein; Chief Editor: Burke A Cunha, MD   more...
 
Updated: Aug 12, 2011
 

Background

Yaws is a contagious, nonvenereal, treponemal infection in humans that mainly occurs in children younger than 15 years. Infection with Treponema pertenue, a subspecies of Treponema pallidum, causes the disease, which occurs primarily in warm, humid, tropical areas of Africa, Asia, South America, and Oceania among poor rural populations where conditions of overcrowding and poor sanitation prevail.

Next

Pathophysiology

The major route of infection is through direct person-to-person contact. The treponemes associated with yaws are located primarily in the epidermis. The ulcerative skin lesions that develop early in the disease course are teeming with spirochetes, which can be transmitted via direct skin-to-skin contact and via breaks in the skin due to trauma, bites, or excoriations.

Yaws, like syphilis, has been classified into the following 4 stages:

  1. Primary stage: The initial yaws lesion develops at the inoculation site.
  2. Secondary stage: Widespread dissemination of treponemes results in multiple skin lesions similar to the primary yaws lesion.
  3. Latent stage: Symptoms are usually absent, but skin lesions can relapse.
  4. Tertiary stage: Bone, joint, and soft tissue deformities may occur.

Another classification distinguishes early yaws from late yaws. Early yaws includes primary and secondary stages and is characterized by the presence of contagious skin lesions. Late yaws includes the tertiary stage, when lesions are not contagious.

Previous
Next

Epidemiology

Frequency

United States

Yaws does not occur in the United States.

International

An estimated 50-100 million persons were infected with yaws before mass treatment campaigns in the 1950s. In the 1970s, yaws cases declined to fewer than 2 million. In the 1980s, fewer than 500 cases per year were reported in the Western Hemisphere. A resurgence of yaws has occurred in West and Central Africa, Southeast Asia, and the Pacific Islands, with recent outbreaks in Thailand, India, Indonesia, Papua New Guinea, and the Solomon Islands. Sporadic cases are reported in South America.

Mortality/Morbidity

  • In most patients, yaws remains limited to the skin, but early bone and joint involvement can occur. Although yaws lesions disappear spontaneously, secondary bacterial infections and scarring are common complications.
  • After 5-10 years, 10% of untreated patients develop destructive lesions that involve bone, cartilage, skin, and soft tissue, similar to those seen in tertiary syphilis. In contrast to venereal syphilis, cardiovascular and neurological abnormalities almost never occur in patients with yaws.

Sex

  • Yaws has no sexual predilection.

Age

  • Yaws predominantly affects children younger than 15 years. The peak incidence is in children aged 6-10 years.
Previous
Proceed to Clinical Presentation
 
 
Contributor Information and Disclosures
Author

Natalie C Klein  MD, PhD, Associate Director, Infectious Disease Division, Associate Professor of Medicine, The School of Medicine at Stony Brook University Medical Center

Natalie C Klein is a member of the following medical societies: American College of Physicians, American Medical Association, American Society for Microbiology, Infectious Diseases Society of America, and New York County Medical Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Gary L Gorby, MD  Associate Professor, Departments of Internal Medicine and Medical Microbiology and Immunology, Division of Infectious Diseases, Creighton University School of Medicine; Associate Professor of Medicine, University of Nebraska Medical Center; Associate Chair, Omaha Veterans Affairs Medical Center

Gary L Gorby, MD is a member of the following medical societies: Alpha Omega Alpha, American Medical Association, American Society for Microbiology, Infectious Diseases Society of America, and New York Academy of Sciences

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Richard B Brown, MD, FACP  Chief, Division of Infectious Diseases, Baystate Medical Center; Professor, Department of Internal Medicine, Tufts University School of Medicine

Richard B Brown, MD, FACP is a member of the following medical societies: Alpha Omega Alpha, American College of Chest Physicians, American College of Physicians, American Medical Association, American Society for Microbiology, Infectious Diseases Society of America, and Massachusetts Medical Society

Disclosure: Nothing to disclose.

Eleftherios Mylonakis, MD  Clinical and Research Fellow, Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital

Eleftherios Mylonakis, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Society for Microbiology, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Chief Editor

Burke A Cunha, MD  Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital

Burke A Cunha, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

References

  1. Scolnik D, Aronson L, Lovinsky R, Toledano K, Glazier R, Eisenstadt J, et al. Efficacy of a targeted, oral penicillin-based yaws control program among children living in rural South America. Clin Infect Dis. May 15 2003;36(10):1232-8. [Medline].

  2. Agmon-Levin N, Bat-sheva PK, Barzilai O, Ram M, Lindeberg S, Frostegård J, et al. Antitreponemal antibodies leading to autoantibody production and protection from atherosclerosis in Kitavans from Papua New Guinea. Ann N Y Acad Sci. Sep 2009;1173:675-82. [Medline].

  3. Anselmi M, Araujo E, Narvaez A, Cooper PJ, Guderian RH. Yaws in Ecuador: impact of control measures on the disease in the Province of Esmeraldas. Genitourin Med. Dec 1995;71(6):343-6. [Medline].

  4. Antal GM, Lukehart SA, Meheus AZ. The endemic treponematoses. Microbes Infect. Jan 2002;4(1):83-94. [Medline].

  5. Backhouse JL, Hudson BJ. Evaluation of immunoglobulin G enzyme immunoassay for serodiagnosis of yaws. J Clin Microbiol. Jul 1995;33(7):1875-8. [Medline].

  6. Bora D, Dhariwal AC, Lal S. Yaws and its eradication in India--a brief review. J Commun Dis. Mar 2005;37(1):1-11. [Medline].

  7. Chulay JD. Treponema Species (Yaws, Pinta Bejel). In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Vol 2. 5th ed. Philadelphia, Pa: Churchill Livingstone; 2000:2490-4.

  8. Elimination of yaws in India. Wkly Epidemiol Rec. Apr 11 2008;83(15):125-32. [Medline].

  9. Engelkens HJ, Judanarso J, Oranje AP, Vuzevski VD, Niemel PL, van der Sluis JJ, et al. Endemic treponematoses. Part I. Yaws. Int J Dermatol. Feb 1991;30(2):77-83. [Medline].

  10. Engelkens HJ, Vuzevski VD, Stolz E. Nonvenereal treponematoses in tropical countries. Clin Dermatol. Mar-Apr 1999;17(2):143-52; discussion 105-6. [Medline].

  11. Etymologia: yaws. Emerg Infect Dis. Jun 2011;17(6):1082. [Medline].

  12. Farnsworth N, Rosen T. Endemic treponematosis: review and update. Clin Dermatol. May-Jun 2006;24(3):181-90. [Medline].

  13. Fegan D, Glennon MJ, Thami Y, Pakoa G. Resurgence of yaws in Tanna, Vanuatu: time for a new approach?. Trop Doct. Apr 2010;40(2):68-9. [Medline].

  14. Fuchs J, Milbradt R, Pecher SA. Tertiary pinta: case reports and overview. Cutis. Jun 1993;51(6):425-30. [Medline].

  15. Gerstl S, Kiwila G, Dhorda M, Lonlas S, Myatt M, Ilunga BK, et al. Prevalence study of yaws in the Democratic Republic of Congo using the lot quality assurance sampling method. PLoS One. Jul 22 2009;4(7):e6338. [Medline].

  16. Guerrier G, Marcon S, Garnotel L, Deltour R, Schinas S, Mathelin JP, et al. Yaws in Polynesia's Wallis and Futuna Islands: a seroprevalence survey. N Z Med J. Apr 29 2011;124(1333):29-31. [Medline].

  17. Hook III, EW. Treponemal Infections. In: Tropical Infectious Diseases: Principles, Pathogens, and Practice. Vol 1. 5th ed. Philadelphia, Pa: Churchill Livingstone; 1999:527-34.

  18. Lupi O, Madkan V, Tyring SK. Tropical dermatology: bacterial tropical diseases. J Am Acad Dermatol. Apr 2006;54(4):559-78; quiz 578-80. [Medline].

  19. Macgregor JD. Disease in Africa: a medical perspective from the 1950s. Vesalius. Dec 2004;10(2):67-73. [Medline].

  20. Mitjà O, Hays R, Ipai A, Gubaila D, Lelngei F, Kiara M, et al. Outcome predictors in treatment of yaws. Emerg Infect Dis. Jun 2011;17(6):1803-085. [Medline].

  21. Mitjà O, Hays R, Ipai A, Wau B, Bassat Q. Osteoperiostitis in early yaws: case series and literature review. Clin Infect Dis. Mar 15 2011;52(6):771-4. [Medline].

  22. Moise KJ Jr, Milam JD, Carpenter RJ Jr. Changing trends in the diagnosis and treatment of Rh alloimmunization. Tex Med. Nov 1987;83(11):27-32. [Medline].

  23. Nnoruka EN. Skin diseases in south-east Nigeria: a current perspective. Int J Dermatol. Jan 2005;44(1):29-33. [Medline].

  24. Parish JL. Treponemal infections in the pediatric population. Clin Dermatol. Nov-Dec 2000;18(6):687-700. [Medline].

  25. Perine PL, Hopkins DR, Niemel PLA, et al. Handbook of Endemic Treponematoses: Yaws, Endemic Syphilis, and Pinta. Geneva, Switzerland: World Health Organization; 1984.

  26. Radolf JD. Treponema. 1996;[Medline].

  27. Rinaldi A. Yaws: A Second (and Maybe Last?) Chance for Eradication. PLoS Negl Trop Dis. 2008;2(8):e275. [Medline].

  28. Rothschild BM. History of syphilis. Clin Infect Dis. May 15 2005;40(10):1454-63. [Medline].

  29. Sarangapani S, Benjamin L. Posterior segment changes secondary to late yaws. Eye. Oct 2001;15(Pt 5):664-6. [Medline].

  30. Satter EK, Tokarz VA. Secondary yaws: an endemic treponemal infection. Pediatr Dermatol. Jul-Aug 2010;27(4):364-7. [Medline].

  31. Sehgal VN, Jain S, Bhattacharya SN, Thappa DM. Yaws control/eradication. Int J Dermatol. Jan 1994;33(1):16-20. [Medline].

  32. Walker SL, Hay RJ. Yaws-a review of the last 50 years. Int J Dermatol. Apr 2000;39(4):258-60. [Medline].

  33. Young JB, Murphy K. Clinical images. Yaws. Wilderness Environ Med. 2006;17(1):49-51. [Medline].

 
Previous
Next
 
Initial papilloma, also called mother yaw or primary frambesioma (from Perine PL, Hopkins DR, Niemel PLA, et al. Handbook of Endemic Treponematoses: Yaws, Endemic Syphilis, and Pinta. Geneva, Switzerland: World Health Organization; 1984.).
Plantar papillomata with hyperkeratotic macular plantar early yaws (ie, crab yaws) (from Perine PL, Hopkins DR, Niemel PLA, et al. Handbook of Endemic Treponematoses: Yaws, Endemic Syphilis, and Pinta.Geneva, Switzerland: World Health Organization; 1984.).
Osteoperiostitis of the tibia and fibula in early yaws (from Perine PL, Hopkins DR, Niemel PLA, et al. Handbook of Endemic Treponematoses: Yaws, Endemic Syphilis, and Pinta. Geneva, Switzerland: World Health Organization; 1984.).
Early yaws papillomata (from Perine PL, Hopkins DR, Niemel PLA, et al. Handbook of Endemic Treponematoses: Yaws, Endemic Syphilis, and Pinta. Geneva, Switzerland: World Health Organization; 1984.).
Early ulceropapillomatous yaws on the leg (from Perine PL, Hopkins DR, Niemel PLA, et al. Handbook of Endemic Treponematoses: Yaws, Endemic Syphilis, and Pinta. Geneva, Switzerland: World Health Organization; 1984.).
Squamous macular palmar yaws (from Perine PL, Hopkins DR, Niemel PLA, et al. Handbook of Endemic Treponematoses: Yaws, Endemic Syphilis, and Pinta. Geneva, Switzerland: World Health Organization; 1984.).
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.